A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published in Nature Communications, identifies a powerful strategy to overcome drug resistance in breast ...
Explore new findings on drug-resistant breast cancer and how targeting cell cycle regulators may improve treatment outcomes.
CDK2 molecular glue degrader MRT-51443 shows enhanced tumor regression and delayed resistance in breast cancer models, surpassing standard treatments. Details regarding the clinical development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results